Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 19, No. 5-6, 2005   

Free Abstract     Article (References)     Article (PDF 435 KB)     
Free Access

Review Article

Pharmacology of Alzheimer's Disease: Appraisal and Prospects
François Sellala, André Nieoullonb, Géraldine Michelc, Bernard François Michelc, Lucette Lacomblezd, Hugo Geertsg, Alexandra Delini Stulah, Régis Bordete, Danièle Bentué-Ferrerf, Hervé Allainf

aHôpital Universitaire, Strasbourg,
bLaboratoire CNRS - LNCF Neurosciences, and
cHôpitaux Sainte Marguerite et de la Conception, Marseille,
dFédération Neurologie Mazarin/Service de Pharmacologie, Hôpital de la Pitié Salpétrière, Paris,
eLaboratoire de Pharmacologie, Lille, and
fLaboratoire de Pharmacologie, Rennes, France;
gSilico Biosciences, Philadelphia, Pa., USA;
hADI International Institut, Basel, Switzerland

Address of Corresponding Author

Dement Geriatr Cogn Disord 2005;19:229-245 (DOI: 10.1159/000084400)


 goto top of page Key Words

  • Alzheimer's disease
  • Pharmacology
  • Innovation
  • Drug
  • Methodology

 goto top of page Abstract

Ten years after the introduction of the first drug, tacrine, in the treatment of Alzheimer's disease, it seems appropriate to reappraise the pharmacological processes of innovation in the research field of dementia. The aim of this review is to pinpoint concrete improvements achieved in this field, regarding experimental methods and clinical evaluation of the compounds, as well as the neurochemistry of the disease and cellular targets to consider in priority. This review deals with this objective in three parts: (1) assessment of current therapeutics, (2) discussion of the experimental models and clinical practices and (3) prospective drugs of the future. The implementation of considered strategies will require the involvement and close cooperation between political decisions, pharmaceutical companies and the scientific community.

Copyright © 2005 S. Karger AG, Basel


 goto top of page Author Contacts

Danièle Bentué-Ferrer
Department of Pharmacology, Faculté de Médecine, University of Rennes I
2, avenue du Professeur Léon-Bernard, FR-35043 Rennes (France)
Tel. +33 2 23 23 47 13, Fax +33 2 23 23 46 05
E-Mail daniele.bentue-ferrer@univ-rennes1.fr


 goto top of page Article Information

Accepted: October 30, 2004
Published online: March 11, 2005
Number of Print Pages : 17
Number of Figures : 2, Number of Tables : 1, Number of References : 50

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 15767760)
Download Citation
Cited In



This journal is part of the first subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their research paper editing service.


copyright  © 2008 S. Karger AG, Basel